SEC Form SC 13G filed by Bright Minds Biosciences Inc.
$DRUG
Biotechnology: Pharmaceutical Preparations
Health Care
|
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
|
|
SCHEDULE 13G
|
||
|
Under the Securities Exchange Act of 1934
|
||
|
(Amendment No. __)*
|
|
Bright Minds Biosciences Inc.
|
||
|
(Name of Issuer)
|
|
Common Shares
|
||
|
(Title of Class of Securities)
|
|
10919W405
|
||
|
(CUSIP Number)
|
|
October 15, 2024
|
||
|
(Date of Event which Requires Filing of this Statement)
|
Check the appropriate box to designate the rule pursuant to which this Schedule is filed:
[ ] Rule 13d-1(b)
[x] Rule 13d-1(c)
[ ] Rule 13d-1(d)
___________________________________
* The remainder of this cover page shall be filled out for a reporting
person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter the disclosures provided in a prior cover page.
The information required in the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the
Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the Notes).
|
1
|
Names of Reporting Persons.
Cormorant Global Healthcare Master Fund, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
|
(b) [x]
|
|
|
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Cayman Islands
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole
Voting Power
0 shares
|
|
6 Shared
Voting Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
7 Sole
Dispositive Power
0 shares
|
|
|
8 Shared
Dispositive Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
18.79% as of 10/15/24 (19.34% as of 10/16/24)
Refer to Item 4 below.
|
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
|
1
|
Names of Reporting Persons.
Cormorant Global Healthcare GP, LLC
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
|
(b) [x]
|
|
|
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole
Voting Power
0 shares
|
|
6 Shared
Voting Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
7 Sole
Dispositive Power
0 shares
|
|
|
8 Shared
Dispositive Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
18.79% as of 10/15/24 (19.34% as of 10/16/24)
Refer to Item 4 below.
|
|
|
12
|
Type of Reporting Person (See Instructions)
OO (Limited Liability Company)
|
|
1
|
Names of Reporting Persons.
Cormorant Asset Management, LP
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
|
(b) [x]
|
|
|
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
Delaware
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole
Voting Power
0 shares
|
|
6 Shared
Voting Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
7 Sole
Dispositive Power
0 shares
|
|
|
8 Shared
Dispositive Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
18.79% as of 10/15/24 (19.34% as of 10/16/24)
Refer to Item 4 below.
|
|
|
12
|
Type of Reporting Person (See Instructions)
PN (Partnership)
|
|
1
|
Names of Reporting Persons.
Bihua Chen
|
|
2
|
Check the Appropriate Box if a Member of a Group (See Instructions)
|
|
(a) [ ]
|
|
|
(b) [x]
|
|
|
3
|
SEC Use Only
|
|
4
|
Citizenship or Place of Organization.
United States
|
|
Number
of Shares
Beneficially
Owned by
Each
Reporting
Person With
|
5 Sole
Voting Power
0 shares
|
|
6 Shared
Voting Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
7 Sole
Dispositive Power
0 shares
|
|
|
8 Shared
Dispositive Power
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
9
|
Aggregate Amount Beneficially Owned by Each Reporting Person
850,000 shares as of 10/15/24 (875,000 shares as of 10/16/24)
Refer to Item 4 below.
|
|
|
10
|
Check if the Aggregate Amount in Row (9) Excludes Certain Shares (See Instructions)
[ ] N/A
|
|
|
11
|
Percent of Class Represented by Amount in Row (9)*
18.79% as of 10/15/24 (19.34% as of 10/16/24)
Refer to Item 4 below.
|
|
|
12
|
Type of Reporting Person (See Instructions)
IN (Individual)
|
Item 1.
|
(a)
|
Name of Issuer
|
|
Bright Minds Biosciences Inc.
|
|
|
(b)
|
Address of Issuer’s Principal Executive Offices
|
|
19 Vestry Street, New York, NY 10013
|
Item 2.
|
(a)
|
Name of Person Filing
|
|
Cormorant Global Healthcare Master Fund, LP
Cormorant Global Healthcare GP, LLC
Cormorant Asset Management, LP
Bihua Chen
|
|
|
(b)
|
Address of Principal Business Office or, if none, Residence
|
|
200 Clarendon Street, 52nd Floor
Boston, MA 02116
|
|
|
(c)
|
Citizenship
|
|
Cormorant Global Healthcare Master Fund, LP - Cayman Islands
Cormorant Global Healthcare GP, LLC - Delaware
Cormorant Asset Management, LP - Delaware
Bihua Chen - United States
|
|
|
(d)
|
Title of Class of Securities
|
|
Common Shares
|
|
|
(e)
|
CUSIP Number
|
|
10919W405
|
| Item 3. |
If this statement is filed pursuant to §§240.13d-1(b) or 240.13d-2(b) or (c), check whether the person filing is a:
|
|
(a)
|
[ ]
|
Broker or dealer registered under section 15 of the Act (15 U.S.C. 78o).
|
|
(b)
|
[ ]
|
Bank as defined in section 3(a)(6) of the Act (15 U.S.C. 78c).
|
|
(c)
|
[ ]
|
Insurance company as defined in Section 3(a)(19) of the Act (15 U.S.C. 78c).
|
|
(d)
|
[ ]
|
Investment company registered under section 8 of the Investment Company Act of 1940 (15 U.S.C. 80a-8).
|
|
(e)
|
[ ]
|
An investment adviser in accordance with §240.13d-1(b)(1)(ii)(E);
|
|
(f)
|
[ ]
|
An employee benefit plan or endowment fund in accordance with §240.13d-1(b)(1)(ii)(F);
|
|
(g)
|
[ ]
|
A parent holding company or control person in accordance with § 240.13d-1(b)(1)(ii)(G);
|
|
(h)
|
[ ]
|
A savings associations as defined in Section 3(b) of the Federal Deposit Insurance Act (12 U.S.C. 1813);
|
|
(i)
|
[ ]
|
A church plan that is excluded from the definition of an investment company under section 3(c)(14) of the Investment Company Act of 1940 (15 U.S.C. 80a-3);
|
|
(j)
|
[ ]
|
A non-U.S. institution in accordance with §240.13d–1(b)(1)(ii)(J);
|
|
(k)
|
[ ]
|
Group, in accordance with §240.13d-1(b)(1)(ii)(K).
|
| Item 4. |
Ownership***
|
Provide the following information regarding the aggregate number and percentage of the class of securities of the issuer identified
in Item 1.
(a) Amount Beneficially Owned***
The information set forth in Row 9 on the cover page for each Reporting Person is hereby incorporated by reference into this Item 4(a) for each such
Reporting Person.
(b) Percent of Class***
The information set forth in Row 11 on the cover page for each Reporting Person is hereby incorporated by reference into this Item 4(b) for each such
Reporting Person.
(c) Number of shares as to which such person has: ***
(i) sole power to vote or to direct the vote
(ii) shared power to vote or to direct the vote
(iii) sole power to dispose or to direct the disposition of
(iv) shared power to dispose or to direct the disposition of
The information set forth in Rows 5 through 8 on the cover page for each Reporting Person is hereby incorporated by reference into this Item 4(c) for
each such Reporting Person.
*** Shares reported herein for Cormorant Asset Management, LP (“Cormorant”) represent shares which are
beneficially owned by Cormorant Global Healthcare Master Fund, LP (the “Master Fund”), as reported herein. Cormorant Global Healthcare GP, LLC (“GP LLC”) serves as the general partner of the Master Fund. Cormorant serves as the investment manager of
the Master Fund. Bihua Chen serves as the managing member of GP, LLC and the general partner of Cormorant. Each of the Reporting Persons disclaims beneficial ownership of the shares reported herein except to the extent of its or her pecuniary
interest therein.
The percentages reported herein with respect to the Reporting Persons’ holdings are based on information provided by the Issuer to the Reporting
Persons, that there were 4,524,087 shares of Common Shares of the Issuer outstanding as of October 15, 2024.
| Item 5. |
Ownership of Five Percent or Less of a Class
|
If this statement is being filed to report the fact that as of the date hereof the reporting person has ceased to be the
beneficial owner of more than five percent of the class of securities, check the following [ ].
| Item 6. |
Ownership of More than Five Percent on Behalf of Another Person
|
Not applicable.
| Item 7. |
Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company
|
Not applicable.
| Item 8. |
Identification and Classification of Members of the Group
|
Not applicable.
| Item 9. |
Notice of Dissolution of Group
|
Not applicable.
| Item 10. |
Certification
|
By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were not acquired and
are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect.
Exhibits Exhibit
99.1 Joint Filing Agreement by and among the Reporting Persons.
SIGNATURE
After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this Statement is
true, complete and correct.
October 22, 2024
|
|
CORMORANT GLOBAL HEALTHCARE MASTER
|
|
|
|
FUND, LP
|
|
|
|
By:
|
Cormorant Global Healthcare GP, LLC,
|
|
|
|
its General Partner
|
|
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
|
|
CORMORANT GLOBAL HEALTHCARE GP, LLC
|
|
|
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
|
|
CORMORANT ASSET MANAGEMENT, LP
|
|
|
|
By:
|
Cormorant Asset Management GP, LLC,
|
|
|
|
its General Partner
|
|
|
|
|
|
|
By:
|
/s/ Bihua Chen
|
|
|
Bihua Chen, Managing Member
|
|
|
|
|
|
|
|
/s/ Bihua Chen
|
|
|
|
Bihua Chen
|
|